Second Drug OK'd for Ultra-Rare Neurodegenerative Disease

Published Date: 27 Sep 2024

FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why are so many young adults getting cancer?

2.

Breast cancer-related fatigue: The benefits of adapted physical activity

3.

EHA: European Hematology Association

4.

PSMA PET Beats MRI in Prostate Cancer Staging Study

5.

According to research, hospitals can save money and help cancer patients by implementing a basic intervention.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot